EUVIMEDEUVIMED entdecken
Crossref

5,2′,4′-trihydroxy-6,7,5′-trimethoxyflavone-nanoparticle regulation mechanism of basic transcription factor 3 through hypoxia inducible factor-1α ubiquitination mediation to inhibit human hepatoma cell proliferation

Jiaxin Chen, Yixuan Wang, Shuhan Wang, Haoyi Cheng, Dandan Wang, Jinghao Fu, Jinge Hao, Jing Zhang, Xuewu Zhang

Phytomedicine · 2025-11 · 147 · 157236

DOI: 10.1016/j.phymed.2025.157236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025-11. Verfasst von Jiaxin Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Yanbian University, Jilin Province, China. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Liver Neoplasms, Carcinoma, Hepatocellular, Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The main bioactive component of Sorbaria sorbifolia, 5,2',4'-trihydroxy-6,7,5'-trimethoxyflavone (TTF1), exhibits anti-cancer activity in human hepatoma cells. To improve its solubility, it can be prepared as nanoparticles (TTF1-NP), however, their role modulating BTF3/HIF-1α ubiquitination and its downstream glycolytic disruption remains unexplored. PURPOSE: To explore the mechanism by which TTF1-NP inhibits the glycolysis and proliferation of hepatoma cells through BTF3-mediated HIF-1α ubiquitination. STUDY DESIGN AND METHODS: This study investigated TTF1-NP's anti-liver cancer mechanism in vitro and vivo. Under hypoxia, TTF1-NP suppressed hepatoma cell proliferation and glycolysis via CCK-8, cloning, flow cytometry, and western blot. Proteomics and survival analysis linked BTF3 to liver cancer progression. TTF1-NP downregulated BTF3, promoting HIF-1α ubiquitination to inhibit glycolysis, confirmed by overexpression/knockdown experiments. In mouse xenograft and rat primary liver cancer models, TTF1-NP attenuated tumor growth, reduced glycolysis, and enhanced HIF-1α degradation, demonstrating its therapeutic potential. RESULTS: Under hypoxic, TTF1-NP inhibited hepatoma cell proliferation by inducing G0/G1 arrest. TTF1-NP treatment reduced lactate production, ATP, and glucose uptake, and significantly downregulated glycolytic enzymes. It suppressed BTF3 (overexpressed in liver cancer), promoting HIF-1α ubiquitination to block glycolysis and tumor growth. In vivo, TTF1-NP attenuated tumor progression, downregulated BTF3/HIF-1α, enhanced HIF-1α degradation, reduced hepatic radioconcentration and inflammation. Mechanistically, it disrupted BTF3-HIF-1α interaction, promoting HIF-1α ubiquitination and inhibiting glycolytic for antitumor effects. CONCLUSION: TTF1-NP inhibites BTF3, promoting HIF-1α ubiquitination to suppress glycolysis and hepatoma growth, these results offer a novel dual-targeted anti-tumor strategy and lay a solid foundation for the development of S. sorbifolia and TTF1-NP as innovative anti-tumor candidate drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Inducible Factor 1, alpha SubunitLiver NeoplasmsCarcinoma, HepatocellularNanoparticlesFlavonesAntineoplastic Agents, PhytogenicHumansAnimalsCell ProliferationUbiquitinationGlycolysisMiceCell Line, TumorRatsMice, NudeMaleXenograft Model Antitumor AssaysTranscription FactorsMice, Inbred BALB CHep G2 Cells

Stichwörter der Autor:innen

Basic transcription factor 3GlycolysisHypoxia-inducible factor-1αLiver cancerSorbaria sorbifolia

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitHIF1A protein, humanFlavonesAntineoplastic Agents, PhytogenicTranscription Factors

Autor:innen und Institutionen

  • Medical College of Yanbian University, Jilin Province, China.
  • Medical College of Yanbian University, Jilin Province, China. Electronic address: zhangxuewu@ybu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, J., Wang, Y., Wang, S., Cheng, H., Wang, D., Fu, J., Hao, J., Zhang, J., & Zhang, X. (2025). 5,2′,4′-trihydroxy-6,7,5′-trimethoxyflavone-nanoparticle regulation mechanism of basic transcription factor 3 through hypoxia inducible factor-1α ubiquitination mediation to inhibit human hepatoma cell proliferation. Phytomedicine, 147, 157236. https://doi.org/10.1016/j.phymed.2025.157236

Vancouver

Chen J, Wang Y, Wang S, Cheng H, Wang D, Fu J, et al. 5,2′,4′-trihydroxy-6,7,5′-trimethoxyflavone-nanoparticle regulation mechanism of basic transcription factor 3 through hypoxia inducible factor-1α ubiquitination mediation to inhibit human hepatoma cell proliferation. Phytomedicine. 2025;147:157236. doi:10.1016/j.phymed.2025.157236

BibTeX
@article{Chen2025,
  author = {Chen, Jiaxin and Wang, Yixuan and Wang, Shuhan and Cheng, Haoyi and Wang, Dandan and Fu, Jinghao and Hao, Jinge and Zhang, Jing and Zhang, Xuewu},
  title = {5,2′,4′-trihydroxy-6,7,5′-trimethoxyflavone-nanoparticle regulation mechanism of basic transcription factor 3 through hypoxia inducible factor-1α ubiquitination mediation to inhibit human hepatoma cell proliferation},
  journal = {Phytomedicine},
  year = {2025},
  volume = {147},
  pages = {157236},
  doi = {10.1016/j.phymed.2025.157236}
}
Kostenlos starten →